(Q36099546)

12 August 2017

1 reference

title

Immunologic uniqueness of the genital tract: challenge for vaccine development (English)

1 reference

12 August 2017

1 reference

Jiri Mestecky

1

1 reference

PubMed ID

15833098

12 August 2017

Zina Moldoveanu

series ordinal

2

1 reference

PubMed ID

15833098

12 August 2017

Michael W Russell

series ordinal

3

1 reference

12 August 2017

1 May 2005

1 reference

American Journal of Reproductive Immunology

12 August 2017

1 reference

12 August 2017

53

1 reference

12 August 2017

5

1 reference

12 August 2017

208-214

1 reference

Mucosal Immunology of Sexually Transmitted Diseases

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Humoral immune responses to microbial infections in the genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Immunity to vaginal infection by herpes simplex virus type 2 in adult mice: characterization of the immunoglobulins in vaginal mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Generation of female genital tract antibody responses by local or central (common) mucosal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Urethral cytokine and immune responses in Chlamydia trachomatis-infected males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Rectal immunization for induction of specific antibody in the genital tract of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Induction of specific immune responses in the genital tract of women after oral or rectal immunization and rectal boosting with Salmonella typhi Ty 21a vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

The Role of Mucosal Immunity in Prevention of HIV Transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

HIV-specific IgG in cervicovaginal secretions of exposed HIV-uninfected female sexual partners of HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Nonclassical mucosal antibodies predominate in genital secretions of HIV-1 infected chimpanzees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Cross-Clade HIV-1–Specific Neutralizing IgA in Mucosal and Systemic Compartments of HIV-1–Exposed, Persistently Seronegative Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

Detection of Mucosal Antibodies in HIV Type 1-Infected Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.2005.00267.X

10.1111/J.1600-0897.2005.00267.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15833098